Gudurutt Kulkarni, MD
Clinical Cardiac Electrophysiology · Elkhart, INNPI 1326042102
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.6%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 43 manufacturers reported payments, led by Medtronic at 44.9% of the total. Reporting peaked in 2023 at $7,571 and has fallen 57.7% since, to $3,206 in 2025.
Across 499 payments — averaging $47.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$11K
- Boston Scientific$5K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$2K
- Abbott$1K
- Novartis$802
- Johnson & Johnson$687
- plus $4K from 37 others
What the payments were for
- Speaking & faculty fees$1,5006%
- Travel & lodging$9,06238%
- Food & beverage$13,23156%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Watchman$1,925
- LifeVest$1,500
- Micra$1,409
- EVERA MRI XT DR SURESCAN$1,279
- DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER$779
- WATCHMAN Access System$385
- WATCHMAN FLX$367
- AMPLATZER AMULET$298
- AVEIR$243
- AFFERA MAPPING SYSTEM$146
- ARCTIC FRONT ADVANCE$126
- OPTIMIZER$116
How this compares
$23,793 in reported general payments places this provider in the 60th percentile of 72 clinical cardiac electrophysiology providers in Indiana.
See all clinical cardiac electrophysiology providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 430 | $463,960 |
| XareltoRivaroxaban | 165 | $184,665 |
| EntrestoSacubitril/Valsartan | 141 | $184,200 |
| JardianceEmpagliflozin | 58 | $60,397 |
| Dofetilide | 40 | $4,875 |
| Metoprolol Succinate | 416 | $4,461 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 13 | $3,223 |
| SotalolSotalol Hcl | 67 | $1,717 |
| Amiodarone Hcl | 48 | $1,708 |
| Carvedilol | 253 | $1,644 |
| Nebivolol Hcl | 17 | $1,297 |
| Metoprolol Tartrate | 171 | $1,009 |
| Digoxin | 48 | $951 |
| ClopidogrelClopidogrel Bisulfate | 108 | $932 |
| Potassium Chloride | 58 | $917 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $394 | $463,960430 claims |
| Johnson & JohnsonXarelto | $687 | $184,665165 claims |
| NovartisEntresto | $802 | $184,200141 claims |
| Boehringer IngelheimJardiance | $17 | $60,39758 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 72 clinical cardiac electrophysiology providers in Indiana.
Other clinical cardiac electrophysiology in Elkhart
- Eric PrystowskyIndianapolis$1.1M
- Chad BonhommeWestfield$925K
- Kevin TrulockIndianapolis$402K
- Sharath VipparthyIndianapolis$114K
- Jasen GilgeIndianapolis$93K
- Vincent KeatingIndianapolis$80K
- Christopher ReedIndianapolis$80K
- Marcelle StuckyIndianapolis$76K
- Joseph SzwedIndianapolis$67K
- Krishna MalineniIndianapolis$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.